[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Neuromodulation Devices Market Size, Share & Trends Analysis Report By Product Type (Spinal Cord Stimulators, Deep Brain Stimulators), By Technology, By Application, By Biomaterial, By End-use, By Region, And Segment Forecasts, 2022 - 2030

July 2022 | 100 pages | ID: NBCD175C4B9CEN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 1 Business Day

Neuromodulation Devices Market Growth & Trends

The global neuromodulation devices market size is expected to reach USD 8.3 billion by 2030, based on a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.5% from 2022 to 2030. Neuromodulation offers minimally invasive or non-invasive treatment options for the treatment of neurological diseases. In addition, the growth in the healthcare budgetary allocation in developing countries is expected to contribute to the market growth. For instance, in the U.S., national healthcare spending increased to USD 4.1 trillion in 2020, or USD 12,530 per person.

The COVID-19 pandemic had caused havoc in a variety of industries and trades around the world. The demand for neuromodulation is higher among the older population as they are more likely to be exposed to chronic pain due to various comorbidities and probable immune suppression. Furthermore, the demand is expected to increase among persons infected with the COVID-19 virus. The illness effectively suppresses the immune system.

The significant increase in investments by the government and market players to improve the healthcare infrastructure is promoting the implementation of novel technologies to treat neurological conditions. In the Union Budget of 2021, the PM Atmanirbhar Swasth Bharat Yojana received funding from the government of India totaling USD 8.10 billion over six years. The fund was allocated to strengthen existing national medical institutions to develop capacities of primary, secondary, and tertiary healthcare systems and cater to the detection of emerging diseases.

Major players operating in the market are receiving FDA approval for their products. The organizations are incorporating strategies such as alliances, acquisitions, partnerships, R&D investments, new product launches, and approvals to strengthen their competitive power while expanding their global reach. For instance, in September 2021, Abbott acquired Walk Vascular, LLC, which is a medical device manufacturing company. Walk Vascular, LLC is known for the minimally invasive thrombectomy system that is designed for the removal of blood clots.

Neuromodulation Devices Market Report Highlights
  • Based on product type, the spinal cord stimulators segment dominated the market with a revenue share of over 40.0% in 2021. Deep brain stimulators are expected to register the fastest growth rate of 10.8% over the forecast period owing to an increase in the usage of deep brain stimulators for treating essential tremors, Parkinson’s disease, dystonia, and epilepsy
  • Based on technology, the internal segment dominated the market with a share of over 55.0% in 2021 owing to the increased use of minimally invasive treatments for treating various neurological disorders. The external segment is expected to expand at the fastest CAGR of 10.8% during the forecast period
  • Based on application, the Parkinson’s disease segment held the largest revenue share of over 25.0% in 2021. The chronic pain segment is expected to exhibit the fastest growth of 11.3% during the forecast period
  • Based on biomaterial, the metallic biomaterials segment dominated the market and held over 45.0% share in 2021 owing to the growth in R&D activities
  • In 2021, North America dominated the market with a revenue share of over 45.0% owing to the rising prevalence of various types of neurological illnesses and the recurring need for neuromodulation devices and therapies. Asia Pacific is expected to expand at the fastest rate of 10.6% during the forecast period. The growth can be attributed to an aging population and rising government initiatives. For instance, NITI Aayog along with the Ministry of Health and Family Welfare launched a no-cost diagnostic program for patients suffering from neurological disorders in 2016
CHAPTER 1 REPORT SCOPE AND OBJECTIVES

1.1 Market Segmentation & Scope
1.2 Regional Scope
  1.2.1 Estimates And Forecast Timeline
1.3 Objectives
  1.3.1 Objective -
  1.3.2 Objective -
  1.3.3 Objective -

CHAPTER 2 METHODOLOGY

2.1 Research Methodology
2.2 Information Procurement
  2.2.1 Purchased Database
  2.2.2 GVR’s Internal Database
  2.2.3 Secondary Sources
  2.2.4 Primary Research
2.3 Information or Data Analysis
  2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
  2.5.1 Commodity Flow Analysis (Model 1)
  2.5.2 Volume Price Analysis (Model 2)
2.6 List of Secondary Sources

CHAPTER 3 EXECUTIVE SUMMARY

3.1 Market Outlook
3.2 Segment Outlook
  3.2.1 Product Type
  3.2.2 Technology
  3.2.3 Application
  3.2.4 Biomaterial
  3.2.5 End Use
  3.2.6 Region
3.3 Competitive Insights
3.4 Neuromodulation Devices Market Outlook, 2021

CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE

4.1 Market Lineage Outlook
  4.1.1 Parent Market Outlook
  4.1.2 Ancillary Market Outlook
4.2 Neuromodulation Devices Market Dynamics
  4.2.1 Market Driver Analysis
    4.2.1.1 Harnessing digital health solutions
    4.2.1.2 A rise in the number of patients with neurological disorders
  4.2.2 Market Restraint Analysis
    4.2.2.1 Less number of skilled labor
4.3 Neuromodulation Devices Market: Business Environment Analysis Tools
  4.3.1 Porter’s Five Forces Analysis
    4.3.1.1 Threat of new entrants
    4.3.1.2 Bargaining power of suppliers
    4.3.1.3 Bargaining power of buyers
    4.3.1.4 Competitive rivalry
    4.3.1.5 Threat of substitutes
  4.3.2 Pestel Analysis
    4.3.2.1 Political & Legal
    4.3.2.2 Economic & Social
    4.3.2.3 Technological
    4.3.2.4 Environmental
4.4 Penetration & Growth Prospect Mapping
4.5 Technology Trend Analysis
4.6 Regulatory Framework
4.7 Impact of COVID-19 on Neuromodulation Devices Market

CHAPTER 5 NEUROMODULATION DEVICES MARKET: PRODUCT TYPE ANALYSIS

5.1 Neuromodulation Devices Product Type Market Share Analysis, 2021 & 2030
5.2 Neuromodulation Devices Product Type Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Type Segment
  5.3.1 Spinal Cord Stimulators
    5.3.1.1 Spinal cord stimulators market, 2017 - 2030 (USD Million)
  5.3.2 Deep Brain Stimulators
    5.3.2.1 Deep brain stimulators market, 2017 - 2030 (USD Million)
  5.3.3 Sacral Nerve Stimulators
    5.3.3.1 Sacral nerve stimulators market, 2017 - 2030 (USD Million)
  5.3.4 Vagus Nerve Stimulators
    5.3.4.1 Vagus nerve stimulators market, 2017 - 2030 (USD Million)
  5.3.5 Transcranial Magnetic Stimulators
    5.3.5.1 Transcranial magnetic stimulators market, 2017 - 2030 (USD Million)
  5.3.6 Others
    5.3.6.1 Others market, 2017 - 2030 (USD Million)

CHAPTER 6 NEUROMODULATION DEVICES MARKET: TECHNOLOGY ANALYSIS

6.1 Neuromodulation Devices Technology Market Share Analysis, 2021 & 2030
6.2 Neuromodulation Devices technology Market: Segment Dashboard:
6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Technology Segment
  6.3.1 Internal
    6.3.1.1 Internal market, 2017 - 2030 (USD Million)
  6.3.2 External
    6.3.2.1 External market, 2017 - 2030 (USD Million)

CHAPTER 7 NEUROMODULATION DEVICES MARKET: APPLICATION ANALYSIS

7.1 Neuromodulation Devices Application Market Share Analysis, 2021 & 2030
7.2 Neuromodulation Devices Application Market: Segment Dashboard
7.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Application Segment
  7.3.1 Parkinson’s Disease
    7.3.1.1 Parkinson’s disease market, 2017- 2030 (USD Million)
  7.3.2 Chronic Pain
    7.3.2.1 Chronic pain market, 2017 - 2030 (USD Million)
  7.3.3 Migraine
    7.3.3.1 Migraine market, 2017- 2030 (USD Million)
  7.3.4 Epilepsy
    7.3.4.1 Epilepsy market, 2017- 2030 (USD Million)
  7.3.5 Tremor
    7.3.5.1 Tremor market, 2017- 2030 (USD Million)
  7.3.6 Depression
    7.3.6.1 Depression market, 2017- 2030 (USD Million)
  7.3.7 Urinary & Fecal Incontinence
    7.3.7.1 Urinary & fecal incontinence, 2017- 2030 (USD Million)
  7.3.8 Others
    7.3.8.1 Others market, 2017- 2030 (USD Million)

CHAPTER 8 NEUROMODULATION DEVICES MARKET: BIOMATERIAL ANALYSIS

8.1 Neuromodulation Devices Biomaterial Market Share Analysis, 2021 & 2030
8.2 Neuromodulation Devices Biomaterial Market: Segment Dashboard
8.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Biomaterial
  8.3.1 Polymeric Biomaterial
    8.3.1.1 Polymeric biomaterial market, 2017- 2030 (USD Million)
  8.3.2 Metallic Biomaterial
    8.3.2.1 Metallic biomaterial market, 2017 - 2030 (USD Million)
  8.3.3 Ceramic Biomaterial
    8.3.3.1 Ceramic biomaterial market, 2017- 2030 (USD Million)

CHAPTER 9 NEUROMODULATION DEVICES MARKET: END-USE ANALYSIS

9.1 Neuromodulation Devices Type Market Share Analysis, 2021 & 2030
9.2 Neuromodulation Devices Type Market: Segment Dashboard
9.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End-Use Segment
  9.3.1 Clinics & Physiotherapy Centers
    9.3.1.1 Clinics & physiotherapy centers market, 2017- 2030 (USD Million)
  9.3.2 Hospitals & Ambulatory Centers
    9.3.2.1 Hospitals & ambulatory centers market, 2017- 2030 (USD Million)
  9.3.3 Others
    9.3.3.1 Others market, 2017- 2030 (USD Million)

CHAPTER 10 NEUROMODULATION DEVICES MARKET: REGIONAL ANALYSIS

10.1 Neuromodulation Devices Regional Market Share Analysis, 2021 & 2030
10.2 Regional Market Snapshot
10.3 North America
  10.3.1 North America Neuromodulation Devices Market, 2017 - 2030 (USD Million)
  10.3.2 U.S.
    10.3.2.1 U.S. neuromodulation devices market, 2017 - 2030 (USD Million)
  10.3.3 Canada
    10.3.3.1 Canada neuromodulation devices market, 2017 - 2030 (USD Million)
10.4 Europe
  10.4.1 Europe Neuromodulation Devices Market, 2017 - 2030 (USD Million)
  10.4.2 U.K.
    10.4.2.1 U.K. neuromodulation devices market, 2017 - 2030 (USD Million)
  10.4.3 Germany
    10.4.3.1 Germany neuromodulation devices market, 2017 - 2030 (USD Million)
  10.4.4 France
    10.4.4.1 France neuromodulation devices market, 2017 - 2030 (USD Million)
  10.4.5 Italy
    10.4.5.1 Italy neuromodulation devices market, 2017 - 2030 (USD Million)
  10.4.6 Spain
    10.4.6.1 Spain neuromodulation devices market, 2017 - 2030 (USD Million)
10.5 Asia Pacific
  10.5.1 Asia Pacific Neuromodulation Devices Market, 2017 - 2030 (USD Million)
  10.5.2 Japan
    10.5.2.1 Japan neuromodulation devices market, 2017 - 2030 (USD Million)
  10.5.3 China
    10.5.3.1 China neuromodulation devices market, 2017 - 2030 (USD Million)
  10.5.4 India
    10.5.4.1 India neuromodulation devices market, 2017 - 2030 (USD Million)
10.6 Latin America
  10.6.1 Latin America Neuromodulation Devices Market, 2017 - 2030 (USD Million)
  10.6.2 Brazil
    10.6.2.1 Brazil neuromodulation devices market, 2017 - 2030 (USD Million)
  10.6.3 Mexico
    10.6.3.1 Mexico neuromodulation devices market, 2017 - 2030 (USD Million)
10.7 Middle East and Africa (MEA)
  10.7.1 MEA Neuromodulation Devices Market, 2017 - 2030 (USD Million)
  10.7.2 South Africa
    10.7.2.1 South Africa neuromodulation devices market, 2017 - 2030 (USD Million)

CHAPTER 11 COMPETITIVE ANALYSIS

11.1 Recent Developments & Impact Analysis, By Key Market Participants
11.2 Company Profiles
  11.2.1 MEDTRONIC
    11.2.1.1 Company overview
    11.2.1.2 Financial performance
    11.2.1.3 Product benchmarking
    11.2.1.4 Strategic initiatives
  11.2.2 LIVANOVA PLC
    11.2.2.1 Company overview
    11.2.2.2 Financial performance
    11.2.2.3 Product benchmarking
    11.2.2.4 Strategic initiatives
  11.2.3 NEVRO CORPORATION
    11.2.3.1 Company overview
    11.2.3.2 Financial performance
    11.2.3.3 Product benchmarking
    11.2.3.4 Strategic initiatives
  11.2.4 BIOVENTUS INC.
    11.2.4.1 Company overview
    11.2.4.2 Financial performance
    11.2.4.3 Product benchmarking
    11.2.4.4 Strategic initiatives
  11.2.5 NEUROPACE INC.
    11.2.5.1 Company overview
    11.2.5.2 Financial performance
    11.2.5.3 Product benchmarking
    11.2.5.4 Strategic initiatives
  11.2.6 BOSTON SCIENTIFIC CORPORATION
    11.2.6.1 Company overview
    11.2.6.2 Financial performance
    11.2.6.3 Product benchmarking
    11.2.6.4 Strategic initiatives
  11.2.7 ABBOTT LABORATORIES
    11.2.7.1 Company overview
    11.2.7.2 Financial performance
    11.2.7.3 Product benchmarking
    11.2.7.4 Strategic initiative
  11.2.8 NEURONETICS
    11.2.8.1 Company overview
    11.2.8.2 Financial performance
    11.2.8.3 Product benchmarking
    11.2.8.4 Strategic initiatives
  11.2.9 INSPIRE MEDICAL SYSTEM INC.
    11.2.9.1 Company overview
    11.2.9.2 Fperformance
    11.2.9.3 Product benchmarking
    11.2.9.4 Strategic initiatives
  11.2.10 ELECTROCORE INC.
    11.2.10.1 Company overview
    11.2.10.2 Financial performance
    11.2.10.3 Product benchmarking
    11.2.10.4 Strategic initiatives
LIST OF TABLES

TABLE 1 List of secondary sources
TABLE 2 North America neuromodulation devices market estimates and forecasts, by country, 2017 - 2030 (USD Million)
TABLE 3 North America neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 4 North America neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 5 North America neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 6 North America neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 7 North America neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 8 U.S. neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 9 U.S. neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 10 U.S. neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 11 U.S. neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 12 U.S. neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 13 Canada neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 14 Canada neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 15 Canada neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 16 Canada neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 17 Canada neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 18 Europe neuromodulation devices market estimates and forecasts, by country, 2017 - 2030 (USD Million)
TABLE 19 Europe neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 20 Europe neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 21 Europe neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 22 Europe neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 23 Europe neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 24 U.K. neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 25 U.K. neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 26 U.K. neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 27 U.K. neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 28 U.K. neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 29 Germany neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 30 Germany neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 31 Germany neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 32 Germany neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 33 Germany neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 34 France neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 35 France neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 36 France neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 37 France neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 38 France neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 39 Italy neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 40 Italy neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 41 Italy neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 42 Italy neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 43 Italy neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 44 Spain neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 45 Spain neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 46 Spain neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 47 Spain neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 48 Spain neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 49 Asia Pacific neuromodulation devices market estimates and forecasts, by country, 2017 - 2030 (USD Million)
TABLE 50 Asia Pacific neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 51 Asia Pacific neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 52 Asia Pacific neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 53 Asia Pacific neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 54 Asia Pacific neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 55 Japan neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 56 Japan neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 57 Japan neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 58 Japan neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 59 Japan neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 60 China neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 61 China neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 62 China neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 63 China neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 64 China neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 65 India neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 66 India neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 67 India neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 68 India neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 69 India neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 70 Latin America neuromodulation devices market estimates and forecasts, by country, 2017 - 2030 (USD Million)
TABLE 71 Latin America neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 72 Latin America neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 73 Latin America neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 74 Latin America neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 75 Latin America neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 76 Brazil neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 77 Brazil neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 78 Brazil neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 79 Brazil neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 80 Brazil neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 81 Mexico neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 82 Mexico neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 83 Mexico neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 84 Mexico neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 85 Mexico neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 86 MEA neuromodulation devices market estimates and forecasts, by country, 2017 - 2030 (USD Million)
TABLE 87 MEA neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 88 MEA neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 89 MEA neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 90 MEA neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 91 MEA neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
TABLE 92 South Africa neuromodulation devices market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
TABLE 93 South Africa neuromodulation devices market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 94 South Africa neuromodulation devices market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 95 South Africa neuromodulation devices market estimates and forecasts, by biomaterials, 2017 - 2030 (USD Million)
TABLE 96 South Africa neuromodulation devices market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
LIST OF FIGURES

FIG. 1 Neuromodulation devices market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Neuromodulation devices market outlook, 2021 (USD Million)
FIG. 10 Market trends & outlook
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 Neuromodulation devices product type market share analysis, 2021 & 2030 (USD Million)
FIG. 15 Neuromodulation devices product type market: Segment dashboard
FIG. 16 Spinal cord stimulators market, 2017 - 2030 (USD Million)
FIG. 17 Deep brain stimulators market, 2017 - 2030 (USD Million)
FIG. 18 Sacral nerve stimulators segmentation market, 2017 - 2030 (USD Million)
FIG. 19 Vagus nerve stimulators market, 2017 - 2030 (USD Million)
FIG. 20 Transcranial magnetic stimulators market, 2017 - 2030 (USD Million)
FIG. 21 Others market, 2017 - 2030 (USD Million)
FIG. 22 Neuromodulation devices technology market share analysis, 2021 & 2030 (USD Million)
FIG. 23 Neuromodulation devices technology market: Segment dashboard
FIG. 24 Internal market, 2017 - 2030 (USD Million)
FIG. 25 External market, 2017 - 2030 (USD Million)
FIG. 26 Neuromodulation devices application market share analysis, 2021 & 2030 (USD Million)
FIG. 27 Neuromodulation devices application market: Segment dashboard
FIG. 28 Parkinson’s disease market, 2017 - 2030 (USD Million)
FIG. 29 Chronic pain market, 2017 - 2030 (USD Million)
FIG. 30 Migraine market, 2017 - 2030 (USD Million)
FIG. 31 Epilepsy market, 2017 - 2030 (USD Million)
FIG. 32 Tremor market, 2017 - 2030 (USD Million)
FIG. 33 Chronic pain market, 2017 - 2030 (USD Million)
FIG. 34 Chronic pain market, 2017 - 2030 (USD Million)
FIG. 35 Others market, 2017 - 2030 (USD Million)
FIG. 36 Neuromodulation devices biomaterial market share analysis, 2021 & 2030 (USD Million)
FIG. 37 Neuromodulation devices biomaterial market: Segment dashboard
FIG. 38 Polymeric biomaterial market, 2017 - 2030 (USD Million)
FIG. 39 Metallic biomaterial market, 2017 - 2030 (USD Million)
FIG. 40 Ceramic biomaterial market, 2017 - 2030 (USD Million)
FIG. 41 Neuromodulation devices end-use market share analysis, 2021 & 2030 (USD Million)
FIG. 42 Neuromodulation devices end-use market: Segment dashboard
FIG. 43 Clinics & physiotherapy centers market segmentation market, 2017 - 2030 (USD Million)
FIG. 44 Hospitals & ambulatory centers market segmentation market, 2017 - 2030 (USD Million)
FIG. 45 Others market segmentation market, 2017 - 2030 (USD Million)
FIG. 46 Healthcare customer data platform regional market share analysis, 2021 & 2030 (USD Million)
FIG. 47 Regional market place: Key takeaways
FIG. 48 North America neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 49 U.S. neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 50 Canada neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 51 Europe neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 52 U.K. neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 53 Germany neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 54 France neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 55 Italy neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 56 Spain neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 57 Asia Pacific neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 58 Japan neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 59 China neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 60 India neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 61 Latin America neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 62 Brazil neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 63 Mexico neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 64 MEA neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 65 South Africa neuromodulation devices market, 2017 - 2030 (USD Million)
FIG. 66 Strategy framework


More Publications